Results 11 to 20 of about 1,665,397 (307)

Masked Hypertension: A Systematic Review

open access: yesHeart Lung and Circulation, 2020
BACKGROUND Masked phenomenon, Masked Hypertension (MHT) and Masked Uncontrolled Hypertension (MUCH) is a well-defined clinical entity. However, many aspects of MHT/MUCH remain unclear.
Mahesan Anpalahan   +2 more
exaly   +4 more sources

Masked Hypertension: Fragile in More Ways Than One. [PDF]

open access: yesHypertension, 2020
In-office blood pressure (BP) has been the cornerstone of hypertension screening for several decades. As guidelines recommend increasingly stringent BP thresholds for the diagnosis of hypertension, we require increasingly accurate approaches to measure ...
Cohen JB.
europepmc   +5 more sources

An Update on Masked Hypertension [PDF]

open access: yesCurrent Hypertension Reports, 2017
Masked hypertension refers to the phenomenon of having a non-elevated clinic blood pressure (BP) despite having an elevated out-of-clinic BP. Masked hypertension is a common phenotype with a cardiovascular risk profile similar to that of sustained hypertension, defined as elevated clinic and out-of-clinic BP. Current guidelines offer little guidance on
Daichi Shimbo   +2 more
exaly   +5 more sources

Postpartum ambulatory and home blood pressure monitoring in women with history of preeclampsia: Diagnostic agreement and detection of masked hypertension. [PDF]

open access: yesPregnancy Hypertens, 2022
Women with a history of preeclampsia (hxPE) are at a four-fold higher risk for chronic hypertension after pregnancy compared with healthy pregnancy, but ‘masked’ hypertension cases are missed by clinical assessment alone.
Nuckols VR   +6 more
europepmc   +2 more sources

Masked Hypertension in Treated Hypertensive Patients [PDF]

open access: yesAmerican Journal of Hypertension, 2006
We read with interest the Critique article by Clement regarding our article and we are grateful for his comments. However, some aspects need to be clarified to avoid confusion. Clement states that the population we studied may be different from that seen in regular hypertension clinics, and that we come up with a very high prevalence of masked ...
PIERDOMENICO, Sante Donato   +2 more
openaire   +4 more sources

Epidemiology of masked and white-coat hypertension: the family-based SKIPOGH study. [PDF]

open access: yesPLoS ONE, 2014
ObjectiveWe investigated factors associated with masked and white-coat hypertension in a Swiss population-based sample.MethodsThe Swiss Kidney Project on Genes in Hypertension is a family-based cross-sectional study.
Heba Alwan   +17 more
doaj   +4 more sources

The Diagnostic Accuracy of Using Borderline High Office Blood Pressure Thresholds to Diagnose Masked Hypertension According to the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline. [PDF]

open access: yesAm J Hypertens
BACKGROUND The 2017 American College of Cardiology (ACC)/American Heart Association (AHA) BP guideline recommends ambulatory BP monitoring (ABPM) for diagnosing masked hypertension among adults not taking antihypertensive medication with borderline ...
Walsh S   +12 more
europepmc   +2 more sources

Association between D-Dimer and Long-Term Major Adverse Cardiovascular Outcomes in Patients with Masked Hypertension [PDF]

open access: yesMedical Principles and Practice
Objective: We investigated the relationship between D-dimer levels and long-term major adverse cardiovascular events (MACEs) in masked hypertension patients admitted to the cardiology outpatient clinic.
Uğur Köktürk   +6 more
doaj   +2 more sources

Neurogenic Abnormalities in Masked Hypertension [PDF]

open access: yesHypertension, 2007
Patients with hypertension exhibit an increased sympathetic activity. No information exists as to whether this is the case in normotensive individuals in whom there is an increased ambulatory blood pressure, a condition termed “masked” hypertension.
GRASSI, GUIDO   +7 more
openaire   +6 more sources

Total methylated arginine load as a risk parameter in subjects with masked hypertension

open access: yesClinical and Experimental Hypertension, 2020
Asymmetric dimethylarginine, symmetric dimethylarginine, and L-monomethylarginine are originated from the subsequent proteolytic catalysis of methylated arginine residues on different proteins and inhibit the endogenous nitric oxide generation.
Muserref Hosaf   +6 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy